Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications
Ewan Hunter, Alexandre Akoulitchev, Tarun Naithani, Dmitri Pchejetski(University of East Anglia), Thomas Guiel, Ang Tick Suan, Serene Lay Geok Ng, Cheah Soon Keat(Penang Adventist Hospital), Jayne Green, Ann Dring, Rakesh Raman(Kent and Canterbury Hospital), Ryan Powell, Fabian Lee Wei Luen, Chun Ren Lim, Abel Gebregzabhar, Robert K. Heaton(University of California San Diego), Jedd Levine, D. Blum, Heba Alshaker(University of East Anglia), M. Chatziioannou, Ho Kean Fatt, Mutaz Issa, Matthew Salter
Cited by 14
Related Papers
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approach
|Nature|2020|1k
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
|Schizophrenia Research|2015|320
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174